A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample.

Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Original Publication: London : BioMed Central, [2001-

Antimetabolites/*pharmacology ; Bromodeoxyuridine/*pharmacology ; Flow Cytometry/*methods; Animals ; Cell Cycle ; Cell Line, Tumor ; Cell Proliferation ; Female ; G1 Phase ; G2 Phase ; Humans ; Jurkat Cells ; Kinetics ; Mice ; Mice, Inbred DBA ; Models, Statistical ; Neoplasm Transplantation ; Software ; Statistics as Topic

Background: Presently available flow cytometric methods of bromodeoxyuridine (BrdUrd) labelling do not provide information on the cell cycle time (TC) and the growth fraction (GF). In this paper, we describe a novel and simple method to estimate TC and GF from flow cytometric analysis of a single tumour sample after BrdUrd labelling.
Methods: The proposed method is based on two assumptions: (1) the number of labelled cells traversing the cell cycle per unit time is constant and (2) the total number of labelled cells is constant throughout the cycle, provided that cells produced after division are excluded. The total numbers of labelled divided G1 cells, labelled divided S cells, labelled undivided S cells, and labelled undivided G2 cells were obtained for DNA histograms of BrdUrd-positive cells in a collected sample. These cell numbers were used to write equations to determine the durations of cell cycle phases, TC and GF. To illustrate the application of the proposed formulae, cell cycle kinetic parameters were analysed in solid SL2 tumours growing in DBA/2 mice and in human T-leukaemia Jurkat cells in culture.
Results: The suitability of the proposed method for estimating durations of the cell cycle phases, TC and GF was demonstrated. TC in SL2 tumours was found to be relatively constant at 4 and 10 days after tumour implantation (20.3 +/- 1.1 h and 21.6 +/- 0.9 h, respectively). GF in tumours at day 10 was lower than GF at day 4 (54.2 +/- 7.7% vs. 79.2 +/- 5.9%, p = 0.0003). Approximate values of TC and GF of cultured Jurkat cells were 23.9 h and 79.3%, respectively.
Conclusion: The proposed method is relatively simple and permits estimation of the cell cycle parameters, including TC and GF, from a single tumour sample after labelling with BrdUrd. We have shown that this method may be useful in preclinical studies, allowing estimation of changes in GF during growth of murine tumours. Experiments with human Jurkat cells suggest that the proposed method might also prove suitable for measurement of cell kinetics in human tumours. Development of suitable software enabling more objective interpretation of the DNA profile in this method would be desirable.

Erratum in: BMC Cancer. 2006;6:184.

Radiother Oncol. 1999 Jan;50(1):13-23. (PMID: 10225552)
Cytometry. 1998 Jul 1;32(3):233-40. (PMID: 9667513)
Cytometry A. 2005 Jul;66(1):32-40. (PMID: 15915505)
J Cell Physiol. 2000 Mar;182(3):311-22. (PMID: 10653597)
Eur J Surg Oncol. 2000 Jun;26(4):405-17. (PMID: 10873364)
Cytometry. 2000 Sep 1;41(1):1-8. (PMID: 10942890)
Int J Radiat Oncol Biol Phys. 2001 Feb 1;49(2):505-11. (PMID: 11173147)
Int J Radiat Oncol Biol Phys. 2003 Mar 1;55(3):576-82. (PMID: 12573744)
Cytometry. 1985 Nov;6(6):620-6. (PMID: 4064842)
Cell Prolif. 1992 Jan;25(1):31-40. (PMID: 1540682)
Cytometry. 1992;13(8):872-9. (PMID: 1459003)
Am J Clin Pathol. 1994 Aug;102(2):171-5. (PMID: 8042584)
J Clin Oncol. 1995 Aug;13(8):1833-6. (PMID: 7636524)
Cytometry. 1995 Sep 1;21(1):52-61. (PMID: 8529471)
Int J Oncol. 1998 Feb;12(2):245-56. (PMID: 9458346)
Am J Clin Pathol. 1998 Jul;110(1):24-31. (PMID: 9661919)

0 (Antimetabolites)
G34N38R2N1 (Bromodeoxyuridine)

Date Created: 20050924 Date Completed: 20060227 Latest Revision: 20181113

20221213

PMC1261259

10.1186/1471-2407-5-122

16176590